Filing Details

Accession Number:
0001078274-21-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-10 17:03:59
Reporting Period:
2021-12-08
Accepted Time:
2021-12-10 17:03:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
320017 Caladrius Biosciences Inc. CLBS Services-Misc Health & Allied Services, Nec (8090) 222343568
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1078274 S Steven Myers C/O Caladrius Biosciences, Inc.
110 Allen Road, 2Nd Floor
Basking Ridge NJ 07920
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-12-08 33,785 $0.89 146,839 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,434 Indirect By Steven S Myers IRA
Common Stock 1,954 Indirect By Steven S Myers Revocable Trust dated 12/1/2000
Common Stock 802 Indirect By spouse
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8802 to $0.9000, inclusive. The reporting person undertakes to provide Caladrius Biosciences, Inc., any security holder of Caladrius Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  2. Represents 37,735 unvested restricted stock awards granted under Issuer's 2018 Equity Incentive Compensation plan, which will vest on January 11, 2022.